EPHA2 and hepatocellular carcinoma: Finally, on the basis of database analysis, we treated human HCC cells MHCC97-H with COE, performed protein profiling (http://www.proteomexchange.org/, PXD022203), and lastly identified EphA2 as the target of COE action in HCC treatment (Figure 1D).